Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
Level 5 - mechanism / opinion, no new human data
Animal research (preclinical knockin mouse model)
PubMed 26888925 · doi:10.1523/JNEUROSCI.2921-15.2016
What was done
Mice with a knockin mutation of mGlu5 (F1128R; mGlu5(R/R)) that selectively disrupts binding to the scaffolding protein Homer were evaluated. Investigators measured mGlu5 localization at the postsynaptic density, basal and agonist-induced translational signaling, protein synthesis-independent long-term depression, neocortical excitability, audiogenic seizures, and behavioral traits including anxiety and sensorimotor gating to determine whether this mutation recapitulates phenotypes of the Fmr1 knock-out model of fragile X syndrome.
What was found
The abstract provides no numerical values. It reports that despite having normal FMRP levels, mGlu5(R/R) mice exhibited reduced mGlu5 association with the postsynaptic density, enhanced constitutive mGlu5 signaling to protein synthesis, deficits in agonist-induced translational control, protein synthesis-independent long-term depression, neocortical hyperexcitability, audiogenic seizures, and altered behaviors including anxiety and sensorimotor gating deficits.
Why it matters
This work identifies mGlu5-Homer scaffold disruption as a sufficient molecular mechanism to drive core neurophysiological, biochemical, and behavioral phenotypes of fragile X syndrome in mice, highlighting a specific pathway relevant to autism and intellectual disability research.
Limits
Findings are restricted to a mouse model and may not directly translate to human neurobiology. The abstract reports no quantitative values, sample sizes, effect sizes, variance measures, or potential sex-specific differences.
Cited by
- supports Fragile X syndrome model mice exhibit hyperactivity of glutamatergic neuronal networks in their brains.